Certified by Founder
Lodge
AlgoTx
start up
France
- Suresnes, Ile-de-France
- 15/03/2023
- Series B
- $21,157,000
AlgoTx develops novel solutions for complex pain. Our lead program, ATX01, targets highly prevalent Chemotherapy-Induced Peripheral Neuropathy and the orphan disease erythromelalgia.
- Industry Biotechnology Research
- Website https://www.linkedin.com/company/algotx/about/
- LinkedIn https://www.linkedin.com/company/algotx/
Voomi Supply | $10,000,000 | (Mar 10, 2026)
Axiomatic_AI | $18,000,000 | (Mar 10, 2026)
Advocacy | $3,500,000 | (Mar 10, 2026)
Crafting | $5,500,000 | (Mar 10, 2026)
Cylake | $45,000,000 | (Mar 10, 2026)
Augur | $15,000,000 | (Mar 10, 2026)
DiligenceSquared (YC F25) | $5,000,000 | (Mar 10, 2026)
Mirai Robotics | $4,200,000 | (Mar 10, 2026)
Dify | $30,000,000 | (Mar 10, 2026)
Mega | $11,500,000 | (Mar 10, 2026)
Denki (YC F25) | $4,100,000 | (Mar 10, 2026)
KAST | $80,000,000 | (Mar 10, 2026)